Dr. John Studd
clinical gynaecologist

print this page


Table 1 Principal reasons for the low continuation rate for HRT
Table 2 Placebo-controlled studies which have shown the value that oestrogens are effective in the triad of hormone-responsive depressions (1) post-natal depression, (2) premenstrual depression, (3) peri-menopausal depression.
Fig. 1 Data showing that the increase in bone density in 60 year old women receiving percutaneous oestrogens is greater in women with the lowest pre-treatment bone density.
Fig. 2 Ultrasound measurement of skin thickness which decreases after the menopause but increases to normal values following oestrogen therapy.
Fig. 3 The incremental increase in spinal bone density using three doses of oestradiol implants, 25 mg, 50 mg and 75 mgs.
Fig. 4 Improvement in depression in a cross-sectional placebo-controlled study of patients with severe PMS using 200 mcg oestradiol patches.
Fig. 5 Anxiety and depression scores before and after hysterectomy in 200 consecutive patients.